Cargando…

Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19

BACKGROUND: Granulocyte colony stimulating factors (G-CSFs) induce neutrophils proliferation and cytokines production. It has often been used to treat neutropenia without solid evidence of efficacy. It has been demonstrated that respiratory distress is associated with neutropenia recovery but not wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taha, Muhanad, Sharma, Aditi, Soubani, Ayman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515585/ https://www.ncbi.nlm.nih.gov/pubmed/32999856 http://dx.doi.org/10.1016/j.rmcr.2020.101231

Ejemplares similares

Respiratory status deterioration during G-CSF-induced neutropenia recovery
por: Karlin, L, et al.
Publicado: (2005)

Neutropenia and G-CSF in lymphoproliferative diseases
por: Ria, Roberto, et al.
Publicado: (2013)

New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy
por: Theyab, Abdulrahman, et al.
Publicado: (2023)

Forty-One-Year-Old Man with Pulmonary Embolism 5 Months After COVID-19
por: Taha, Muhanad, et al.
Publicado: (2021)

Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion
por: Karst, Allison, et al.
Publicado: (2018)

Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapies
por: Tonra, James R., et al.
Publicado: (2019)

The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
por: Tesfa, Daniel, et al.
Publicado: (2021)

Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
por: Jiang, Yantao, et al.
Publicado: (2023)

G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans
por: Cardot-Ruffino, Victoire, et al.
Publicado: (2023)

Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
por: Kim, Do Young, et al.
Publicado: (2022)

Coronavirus Disease 2019 in Immunocompromised Organ Transplant Recipients: A Case Report and Review of the Literature
por: Taha, Muhanad, et al.
Publicado: (2020)

Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-Stimulating Factor (G-Csf) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-Csf Treatment
por: Ward, Alister C., et al.
Publicado: (1999)

Late-Onset Neutropenia in Long-Term Clozapine Use and Its Management Utilizing Prophylactic G-CSF
por: O' Neill, Eimear, et al.
Publicado: (2021)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

High-flow nasal cannula therapy in a predominantly African American population with COVID-19 associated acute respiratory failure
por: Nguyen, Paul L, et al.
Publicado: (2021)

Splenic rupture, secondary to G-CSF use for chemotherapy induced neutropenia: a case report and review of literature
por: Masood, Nehal, et al.
Publicado: (2008)

Acute respiratory distress syndrome during neutropenia recovery
por: Azoulay, Élie, et al.
Publicado: (2010)

Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
por: Li, Weiwei, et al.
Publicado: (2023)

A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer
por: Zou, Dongling, et al.
Publicado: (2021)

Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia–derived Mutation in the G-CSF Receptor Gene
por: Hermans, Mirjam H.A., et al.
Publicado: (1999)

PEG‐rhG‐CSF for prophylaxis of neutropenia after chemotherapy in patients with non–small cell lung cancer: A multicenter, prospective, randomized study
por: Sun, Xu‐Sheng, et al.
Publicado: (2022)

rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.
por: Rampling, R., et al.
Publicado: (1994)

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
por: Aapro, Matti, et al.
Publicado: (2017)

Burden and impact of arrhythmias in asthma‐related hospitalizations: Insight from the national inpatient sample
por: Taha, Muhanad, et al.
Publicado: (2020)

Maximum daily dose of G-CSF is critical for preventing recurrence of febrile neutropenia in patients with gynecologic cancer: A case–control study
por: Kim, Nam Kyeong, et al.
Publicado: (2022)

Ultra-Sensitive CSF3R Deep Sequencing in Patients With Severe Congenital Neutropenia
por: Klimiankou, Maksim, et al.
Publicado: (2019)

Truncated CSF3 receptors induce pro‐inflammatory responses in severe congenital neutropenia
por: Olofsen, Patricia A., et al.
Publicado: (2022)

Quantification of Radiation Injury on Neutropenia and the Link between Absolute Neutrophil Count Time Course and Overall Survival in Nonhuman Primates Treated with G-CSF
por: Harrold, John, et al.
Publicado: (2020)

Increased FluoroDeoxyGlucose (FDG) Avidity Following COVID-19 Vaccination
por: Nassar, Mo’ath, et al.
Publicado: (2022)

G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke
por: Kollmar, Rainer, et al.
Publicado: (2010)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis
por: Sereno, María, et al.
Publicado: (2021)

A study indicates an essential link between a mild deterioration in excretory kidney function and the risk of neutropenia during cancer chemotherapy
por: Stryczyńska-Mirocha, Adriana, et al.
Publicado: (2023)

Neutropenia during High Dose Intravenous Oxacillin Therapy
por: Ahern, Mary Jean, et al.
Publicado: (1976)

Profound Neutropenia with Concomitant Hepatitis During Oxacillin Therapy
por: Miller, John B, et al.
Publicado: (2019)

Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
por: Bakherad, Hamid, et al.
Publicado: (2020)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

Outcome and Cost-Effectiveness Analysis of Long-acting G-CSF as Primary Prophylaxis of Neutropenia Induced by Chemotherapy in Breast Cancer Patients, From a Retrospective Study
por: Wang, Yaqin, et al.
Publicado: (2023)

Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy
por: Berends, Claudia, et al.
Publicado: (2021)

Immature platelet fraction predicts early marrow recovery after severe chemotherapy associated neutropenia
por: Salvador, Christina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9uvri2f6h83m0840onqgr1n9mg